
In vitro evaluation of 5-arylidene-2-thioxo-4-thiazolidinones active as aldose reductase inhibitors
Keywords: AGEs; advanced glycation-end products; ALR2; aldose reductase; ARIs; aldose reductase inhibitors; 2,4-TZDs; 2,4-thiazolidinediones; Aldose reductase; Enzyme inhibition; Diabetes complications; 4-Thiazolidinones;